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A 49-year-old Caucasian man with type 2 diabetes,
hypertension, hyperlipidemia and obesity, and no known
renal disease presented with 2 weeks of headache and visual
disturbances, and a 6-month history of frothy urine. Diabetes
had been diagnosed 3 years previously and had been under
excellent control; the most recent Hgb A1c was 7.1%. There
was no history of end-organ involvement secondary to
diabetes, including retinopathy and neuropathy. Serum and
urine protein electrophoresis with immunofixation demon-
strated no monoclonal proteins. There was no family history
of kidney disease or malignancy.
On examination, the patient’s body mass index was 43 kg/m2,
blood pressure was 230/100mmHg, and the heart rate was
88/min and regular. The rest of the physical examination was
significant for mild periorbital edema and bilateral, 1þ pitting
ankle edema. Laboratory testing showed a serum creatinine of
4.55mg/dl (baseline a year previously was 1.22mg/dl), blood
urea nitrogen of 38mg/dl, and a 24-h urine total protein
excretion of 10.0 g. Urine microscopy showed 1–2 epithelial
cells/high-power field, but no dysmorphic erythrocytes, cellular
casts, or crystals. Serological studies including anti-nuclear
antibody, anti-ds DNA, anti-neutrophil cytoplasmic antibody,
anti-glomerular basement antibodies, complement levels (C3,
C4), and HIV, hepatitis B and C viral studies were all within the
reference ranges or negative. Serum and urine protein
electrophoresis was negative for monoclonal proteins. A renal
ultrasound revealed normal-sized kidneys, normal echogenicity
bilaterally, and patent renal vasculature. A renal biopsy was
performed for diagnosis. Light microscopic findings are
depicted in Figure 1.
What is the cause of his proteinuria and rapidly declining renal function?
How would you confirm your diagnosis?
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Figure 1 | Every glomerulus in the biopsy was globally
obliterated by a pale eosinophilic amorphous material. The
vessels and interstitium were notably uninvolved. Hematoxylin and
eosin 200.
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The Diagnosis | Hereditary fibrinogen A a amyloidosis
The biopsy revealed obliteration of all glomeruli by amyloid
(Figure 1). Severe tubular atrophy was accompanied by severe
interstitial fibrosis. Congo red staining was positive in the
glomeruli, demonstrating specific apple green birefringence,
but was notably negative in vessels (Figure 2). Immuno-
fluorescent analysis revealed segmental smudgy glomerular
staining with antisera specific for IgG (trace), IgM (1þ ), C1q
(1þ ), and lambda light chain (1þ ). There was no staining
with antisera specific for IgA, C3, fibrin, or kappa light chain.
Ultrastructural analysis of a single glomerulus demonstrated no
immune complex-type electron-dense deposits. Fine fibrillary
material was present within the capillary basement membranes
consistent with amyloid, but was not diagnostic because of
suboptimal resolution. The tissue was referred for immuno-
fluorescent staining with antibodies against the most common
types of hereditary amyloidosis. Although the findings were
suggestive of a diagnosis of fibrinogen (Fib) A a amyloidosis,
the staining intensity was not strong enough for a definitive
diagnosis. Tissue was sent for liquid chromatography tandem
mass spectrometry protein analysis. Intense signals for Fib A a
were seen, which strongly suggested Fib A a amyloid. As Fib A
a can be deposited non-specifically as part of fibrin, genetic
testing for point mutations was performed. Using polymerase
chain reaction amplification and direct DNA sequencing, the
common E526V variant was identified, confirming the
diagnosis of Fib A a amyloidosis.1
Hereditary Fib A a amyloidosis (also known as AFib
amyloidosis) was discovered in 1993.2 It involves an
abnormal protein deposition due to the production of a
variant of fibrinogen by the liver. Because of the slow
progression of the renal disease, it does not usually present
until the fifth or sixth decade and its manifestations include
proteinuria, uncontrolled hypertension, and renal failure.1,2
One series found that Fib A a amyloidosis is the most
common cause of hereditary renal amyloidosis causing
nephrotic syndrome.1 Misdiagnosis as the more common
amyloid light-chain amyloidosis can occur, and thus careful
diagnostic assessment of the specific type of amyloid
deposited in the kidney is critical in ensuring proper
therapy.3 In fact, for all newly diagnosed cases of amyloidosis,
a careful assessment of amyloid type using tissue staining and
polymerase chain reaction amplification and sequencing of
mutated genes may be indicated. The rapid progression of
renal disease, high levels of new-onset proteinuria, and well-
controlled diabetes should suggest a diagnosis other than
diabetic nephropathy.
As synthesis of fibrinogen is exclusively hepatic, a liver
transplant before kidney damage or a combined liver–kidney
transplant will be required for long-term success.3 Without
liver transplantation, the abnormal fibrinogen synthesis will
continue, leading to continued amyloid deposition in the
kidney, as well as in the vasculature and heart, leading to
poor outcomes.
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Figure 2 | Specific apple green birefringence on Congo red
staining seen in all glomeruli, but neither in the vascular walls
nor in the interstitium.
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